VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ASPN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ASPNAspen Aerogels, Inc.
$5.63$467M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksASPNCash Flow

Aspen Aerogels, Inc. (ASPN) Cash Flow Statement

16Y historyFree accessUpdated daily

Despite a net loss of $23.7M, the company reported a $34.1M operating cash inflow in 2026Q1, largely driven by favorable working capital shifts of $48.3M.

ASPN Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'10Dec'09
Cash from Operations61.38M32.87M45.55M-42.61M-94.4M-18.63M-9.92M-1.05M-8.65M-4.61M-578K5.36M6.65M-13.69M-25.88M-15.13M-12.97M
Operating CF Margin %-12.13%10.06%-17.85%-52.34%-15.32%-9.9%-0.76%-8.29%-4.13%-0.49%4.37%6.49%-15.9%-40.78%-35.01%-45.33%
Operating CF Growth %266.44%-27.83%206.89%54.86%-406.76%-87.71%-841.56%87.82%-87.89%-696.89%-110.79%-19.39%148.57%47.11%-71.09%-16.61%-
Net Income-111.99M-389.55M13.38M-45.81M-82.74M-37.09M-21.81M-14.56M-34.44M-19.32M-12.02M-6.42M-66.32M-47.61M-56.14M-9.91M-18.64M
Depreciation & Amortization19.48M45.16M22.53M18.18M9.22M9.44M10.2M10.21M10.79M10.75M9.85M9.89M10.18M10.06M9.68M4.63M5.63M
Stock-Based Compensation5.85M8.63M12.86M09.38M5.18M5M3.77M4.3M5.09M5.31M5.41M8.78M4.43M1.65M468K831K
Deferred Taxes-522K0000-3.82M325K010.28M000119K-4.99M3.87M53K0
Other Non-Cash Items-23.68M320.08M47.75M16.19M7.9M1.64M980K947K-121K-112K656K-139K50.03M36.04M21.64M2.38M3M
Working Capital Changes99.33M48.56M-50.96M-31.17M-38.16M6.03M-4.62M-1.42M540K-1.02M-4.38M-3.38M3.86M-11.62M-6.58M-12.76M-3.79M
Change in Receivables37.27M70.3M-39.36M-12.55M-37.04M-4.64M16.23M-6.69M-1.72M-8.7M3.09M-2.64M838K-4.81M-6.8M-5.97M232K
Change in Inventory25.68M9.3M-8.36M-16.65M-10.55M1.11M-4.33M-1.45M1.6M3.95M-6.34M-1.64M2M-547K3.18M-652K1.59M
Change in Payables-2.28M-19.45M7.34M4.58M5.32M7.38M-7.15M141K1.56M1.27M105K1.52M687K-1.69M1.68M181K-1.29M
Cash from Investing-25.82M-37.45M-86.26M-175.46M-177.97M-13.78M-3.42M-2.11M-3.59M-6.12M-13.22M-21.96M-13.24M-3.33M-9.79M-15.71M-1.78M
Capital Expenditures-25.82M-37.45M-86.26M-175.46M-177.97M-13.78M-3.42M-2.11M-3.59M-6.12M-13.22M-21.96M-13.24M-3.33M-10.24M-11.34M-1.64M
CapEx % of Revenue11.21%13.81%19.05%73.5%98.67%11.33%3.41%1.52%3.44%5.48%11.22%17.92%12.93%3.87%16.13%26.25%5.75%
Acquisitions0000000000021.96M00011.34M0
Investments-----------------
Other Investing0000000000-13.22M-21.96M-13.24M0451K-11.64M-139K
Cash from Financing-52.42M-58.13M122.02M75.48M478.37M92.47M26.2M3.47M4.88M3.33M-924K-318K54.74M17.25M25.77M30.13M30.27M
Debt Issued (Net)-53.9M-59.23M25.59M-623K100M0563K-1.06M431K3.72M-68K-80K-19.93M18.12M26.19M9.72M-269K
Equity Issued (Net)363K1.87M93.84M76.52M391.3M94.42M24.71M0-551K00074.71M05K21.1M30.54M
Dividends Paid00000000000000000
Share Repurchases-115K0000000-551K-391K-200K-238K00000
Other Financing1.12M-765K2.59M-420K-12.93M-1.95M931K4.53M5M-391K-856K-238K-47K-872K-425K-687K0
Net Change in Cash-16.85M-62.71M81.31M-142.59M206M60.07M12.86M306K-7.37M-7.39M-14.72M-16.91M48.15M231K-9.9M-702K15.51M
Free Cash Flow35.57M-4.58M-40.71M-218.07M-272.37M-32.41M-13.34M-3.17M-12.25M-10.72M-13.79M-16.6M-6.59M-17.02M-36.12M-26.47M-14.62M
FCF Margin %15.45%-1.69%-8.99%-91.35%-151.01%-26.64%-13.3%-2.27%-11.74%-9.61%-11.72%-13.55%-6.44%-19.77%-56.92%-61.25%-51.08%
FCF Growth %896.22%88.76%81.33%19.94%-740.5%-142.92%-321.35%74.15%-14.2%22.26%16.89%-151.74%61.26%52.88%-36.45%-81.08%-
FCF per Share0.43-0.06-0.51-3.14-6.92-1.06-0.51-0.13-0.52-0.46-0.60-0.72-0.29-0.74-2.34-1.71-0.95
FCF Conversion (FCF/Net Income)-0.32x-0.08x3.41x0.93x1.14x0.50x0.46x0.07x0.25x0.24x0.05x-0.84x-0.10x0.29x0.46x1.53x0.70x
Interest Paid8.84M000000440K000000000
Taxes Paid402K0000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Manufacturing scale-up execution risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Masked by Accruals

As reported in recent financial statements, the company's operating cash flow frequently diverges from net income, with 2026Q1 showing a $34.1M cash inflow despite a $23.7M net loss, suggesting that non-cash items and working capital shifts are currently driving the primary cash flow narrative.

The persistent gap between net income and operating cash flow indicates that the firm's reported earnings are currently poor indicators of actual liquidity. Investors should monitor whether this cash generation is sustainable or merely a temporary byproduct of aggressive working capital management rather than core operational profitability.

Volatile Free Cash Flow Path

Based on quarterly data, free cash flow has exhibited extreme volatility, swinging from a $43.6M outflow in 2024Q1 to a $32.8M inflow in 2026Q1, which reflects the lumpy nature of capital expenditures and the ongoing transition toward high-volume electric vehicle thermal barrier production.

The erratic trajectory of free cash flow suggests that the company has not yet achieved a stable self-funding mechanism. The reliance on positive swings in working capital to offset operational losses warrants further investigation into the underlying stability of the firm's cash-generating engine.

Capital Intensity Remains Elevated

According to historical cash flow filings, the company has maintained significant capital intensity, with CAPEX as a percentage of revenue peaking at 33.0% in 2023Q4, underscoring the heavy investment required to build out the Georgia manufacturing facility for the EV thermal barrier segment.

The high level of capital expenditure relative to revenue suggests that the firm is still in a heavy growth-capex phase rather than a maintenance-capex cycle. This capital-intensive profile may continue to pressure free cash flow until the new manufacturing capacity reaches optimal utilization levels.

Working Capital as Liquidity Buffer

As indicated by recent SEC filings, working capital changes have been a major source of cash, contributing $48.3M in 2026Q1, which appears to be a critical factor in masking the underlying operational cash burn during the current period of revenue contraction.

The heavy reliance on working capital inflows suggests that the company may be aggressively managing payables or liquidating inventory to preserve cash. Analysts should monitor whether these favorable working capital trends are sustainable or if they represent a temporary deferral of cash outflows that could reverse in future quarters.

ASPN — Frequently Asked Questions

Quick answers to the most common questions about buying ASPN stock.

How much cash does Aspen Aerogels, Inc. (ASPN) generate from operations?

Aspen Aerogels, Inc. (ASPN) generated $32.9M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Aspen Aerogels, Inc.'s free cash flow?

Aspen Aerogels, Inc. (ASPN) reported negative free cash flow of $4.6M in 2025, indicating capital requirements exceeded cash from operations.

What is Aspen Aerogels, Inc.'s capital expenditure (CapEx)?

Aspen Aerogels, Inc. (ASPN) spent $37.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.